扒开大腿狠狠进入的视频_男动漫脱裤子洗澡露蛋视频_男性gay无套浴室_国产桃色精品网站

PRODUCT DISPLAY

Our company is committed to the research and production of high-purity animal and plant extracts, active pharmaceutical ingredients, cosmetic ingredients, and food additives

Cholic acid series products

Ursodeoxycholic acid, as an active pharmaceutical ingredient, can be used to increase bile acid secretion, alter bile composition, reduce cholesterol and cholesterol lipids in bile, and facilitate the gradual dissolution of cholesterol in gallstones.

Other products

It plays a leading and comprehensive role in anti-aging, antioxidant, anti radiation, beauty, liver protection, treatment of alcoholic liver disease and viral hepatitis, blood sugar control, and blood sugar concentration balance.

ABOUT BELLING

Zhongshan Belling Biotechnology Co., Ltd. was founded on April 6, 2004, located in the National Health Industry Base Park of Torch Development Zone, Zhongshan City, Guangdong Province, with a registered capital of 66.66 million RMB. It is a subsidiary of other limited liability companies. The company was recognized as a national high-tech enterprise in 2009, 2012, 2015, and 2018. In 2013, it was awarded the Guangdong Provincial Engineering Technology Research Center for Animal Medicinal Ingredients. In 2015, it successfully passed the new GMP certification for ursodeoxycholic acid. In May 2018, it was recognized as a provincial-level enterprise technology center in Guangdong Province. In August 2019, it obtained the EU CEP certificate.

20
50
50
1000

Focus on bile acid products

Products sold to countries and regions

Obtaining invention patents and certificates

Annual production of starting materials and active pharmaceutical ingredients

Year

Ton

+

Individual

About Belling

Development History

Business Scope

Our company is committed to the research and production of high-purity animal and plant extracts, active pharmaceutical ingredients, cosmetic raw materials, and food additives. Our leading product...

Our company is a leading enterprise in the domestic liver and gallbladder raw material products. Our company's excellent quality of ursodeoxycholic acid raw material has been widely recognized by domestic...

We look forward to long-term win-win cooperation with excellent international pharmaceutical companies to provide professional services for your products to enter the Chinese market.

GLOBAL MARKET

Belling Biological's bile acid products have been officially approved by China, Taiwan, China, the European Union, India, Russia and other countries, and have two EU CEP certificates for ursodeoxycholic acid. The factory has passed the on-site inspection by the US FDA. Every year, hundreds of tons of bile acid products are sold to nearly 50 countries and regions worldwide, including Germany, Russia, India, the United States, Canada, Japan, Argentina, Egypt, Australia, Brazil, and more. The product market share ranks among the top three globally.

LATEST NEWS

Follow Belling Biotechnology to learn more about the latest information on bile acid products

  • 上海交通大學基礎醫學院程金科課題組在一項最新研究中鑒定了腫瘤免疫抑制的重要調控因子SENP1，發現其通過影響MDSC的發育及功能改變腫瘤進程，并提示其在腫瘤臨床治療中的潛在價值。
    2024-08-02
  • 復旦大學藥學院蔣晨課題組與上海醫藥工業研究院陸偉根課題組合作，研發出一種可重塑腦部病灶神經血管單元、治療急性缺血型腦卒中、防止溶栓后副作用的新型聚合物膠束藥物遞送系統。
    2024-08-02
  • 日前，中科院生物物理所范祖森團隊發現并鑒定了一類新的免疫細胞亞群：自然殺傷樣B細胞（NKB cell）。他們還進一步探討了這一類免疫細胞新亞群的發育來源，證明了NKB與B細胞從細胞發育來源上的不同。
    2024-08-02